Logo for BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

Issued & Outstanding90,886,229
Reserved for Issuance20,134,579
CSE Index


BioMark Diagnostics Inc.

Listing date
November 03, 2014

BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology has developed to date into a metabolomics-based diagnostic assay that allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection system up to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com